Retraction notice to "Omicron variant (B.1.1.529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?" [Biomedicine & Pharmacotherapy 154 (2022) 113522] - 25/03/26
Doi : 10.1016/j.biopha.2026.119215
Manish Dhawan a, b, ⁎, AbdulRahman A. Saied c, d, Saikat Mitra e, Fahad A. Alhumaydhi f, Talha Bin Emran g, h, ⁎, Polrat Wilairatana i, ⁎
a Department of Microbiology, Punjab Agricultural University, Ludhiana 141004, Punjab, India
b Trafford College, Altrincham, Manchester WA14 5PQ, UK
c National Food Safety Authority (NFSA), Aswan Branch, Aswan 81511, Egypt
d Ministry of Tourism and Antiquities, Aswan Office, Aswan 81511, Egypt
e Department of Pharmacy, Faculty of Pharmacy, University of Dhaka, Dhaka 1000, Bangladesh
f Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah 52571, Saudi Arabia
g Department of Pharmacy, BGC Trust University Bangladesh, Chittagong 4381, Bangladesh
h Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka 1207, Bangladesh
i Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok 10400, Thailand
⁎ Corresponding authors.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Le texte complet de cet article est disponible en PDF.
© 2026
The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 197
Article 119215- avril 2026 Retour au numéro
Article précédent
- Retraction notice to "Yap-Hippo promotes A549 lung cancer cell death via modulating MIEF1-related mitochondrial stress and activating JNK pathway" [Biomedicine & Pharmacotherapy 113 (2019) 108754]
- Jiayu Zhou, Shizhen Zhang, Zhijun Li, Zhoumiao Chen, Yong Xu, Weiwen Ye, Zhengfu He
- Retraction notice to "Acute myocardial infarction therapy using calycosin and tanshinone co-loaded mitochondria targeted lipid-polymer hybrid nano-system: Preparation, characterization, and anti myocardial infarction activity assessment" [Biomed. Pharmacother. 155 (2022) 113650]
- Jieke Yan, Jing Guo, Yuzhen Wang, Xiaowei Xing, Xuguang Zhang, Guanghao Zhang, Zhaoqiang Dong
Bienvenue sur EM-consulte, la référence des professionnels de santé.